These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21366605)

  • 21. Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis.
    Zhang H; Guo Y; Wang W; Shi M; Chen X; Yao Z
    Allergy; 2011 Mar; 66(3):420-7. PubMed ID: 21039602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atopic dermatitis: systemic immunosuppressive therapy.
    Akhavan A; Rudikoff D
    Semin Cutan Med Surg; 2008 Jun; 27(2):151-5. PubMed ID: 18620137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric atopic dermatitis: a review of the medical management.
    Carbone A; Siu A; Patel R
    Ann Pharmacother; 2010 Sep; 44(9):1448-58. PubMed ID: 20628042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetics of skin barrier impairment in atopic dermatitis].
    Audigier V; Shisha A; Jullien D
    Ann Dermatol Venereol; 2008 Jan; 135(1):34-7. PubMed ID: 18342071
    [No Abstract]   [Full Text] [Related]  

  • 25. What's new in atopic eczema?
    Plötz SG; Ring J
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):249-67. PubMed ID: 20433363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atopic dermatitis. Pathophysiologic background, scientific status quo and therapeutic strategies].
    Goerge T; Schneider SW; Steinhoff M
    Med Monatsschr Pharm; 2005 Aug; 28(8):267-76; quiz 277. PubMed ID: 16128538
    [No Abstract]   [Full Text] [Related]  

  • 27. Atopic dermatitis progression: evaluating intervention strategies.
    Stein Gold LF; Eichenfield LF
    Semin Cutan Med Surg; 2017 Mar; 36(2 Suppl 2):S39-S41. PubMed ID: 28654709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups.
    Czarnecka-Operacz M; Silny W
    Acta Dermatovenerol Croat; 2006; 14(4):230-240. PubMed ID: 17328144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel immunological approaches in the treatment of atopic eczema.
    Belloni B; Andres C; Ollert M; Ring J; Mempel M
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):423-7. PubMed ID: 18769195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the Early Treatment of the Atopic Child (ETAC) population.
    Müller S; Marenholz I; Lee YA; Sengler C; Zitnik SE; Griffioen RW; Meglio P; Wahn U; Nickel R
    Pediatr Allergy Immunol; 2009 Jun; 20(4):358-61. PubMed ID: 19538357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling.
    Angelova-Fischer I; Mannheimer AC; Hinder A; Ruether A; Franke A; Neubert RH; Fischer TW; Zillikens D
    Exp Dermatol; 2011 Apr; 20(4):351-6. PubMed ID: 21410766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis.
    Greisenegger E; Novak N; Maintz L; Bieber T; Zimprich F; Haubenberger D; Gleiss A; Stingl G; Kopp T; Zimprich A
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):607-10. PubMed ID: 19874431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latest approaches to treating atopic dermatitis.
    Paller AS
    Chem Immunol Allergy; 2012; 96():132-140. PubMed ID: 22433383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2014 update on atopic dermatitis in children.
    Totri CR; Diaz L; Eichenfield LF
    Curr Opin Pediatr; 2014 Aug; 26(4):466-71. PubMed ID: 24926800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are biologics safe in the treatment of atopic dermatitis? A review with a focus on immediate hypersensitivity reactions.
    Bremmer MS; Bremmer SF; Baig-Lewis S; Simpson EL
    J Am Acad Dermatol; 2009 Oct; 61(4):666-76. PubMed ID: 19646779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in the treatment of adult atopic dermatitis.
    Pua VS; Barnetson RS
    Australas J Dermatol; 2006 May; 47(2):84-9. PubMed ID: 16637800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options in the treatment of psoriasis and atopic dermatitis.
    Gottlieb AB
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S3-16. PubMed ID: 15968262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
    Roekevisch E; Leeflang MMG; Schram ME; Campbell LE; Irwin McLean WH; Kezic S; Bos JD; Spuls PI; Middelkamp-Hup MA
    Br J Dermatol; 2017 Dec; 177(6):1745-1746. PubMed ID: 27864930
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical treatment for atopic dermatitis in the 21st century.
    Johnson SM; Kincannon JM; Dudney DL;
    J Ark Med Soc; 2004 Sep; 101(3):86-90. PubMed ID: 15384500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.